This Biotech Startup Is Using AI To Help Researchers Develop Cures Quicker

The increased use of artificial intelligence and machine learning is steadily shifting the paradigm of medical research and treatment, providing researchers real-time access to every white paper and clinical case study conducted on a genetic disorder. Being able to develop such an elaborate database of information allows researchers to not only understand the full scope of a medical condition, but further shorten the amount of time it takes to develop a cure. Founded in 2011, Innoplexus is a technology and product development company focused on solving complex challenges in the pharmaceutical and life sciences industries. Their end-to-end platform for Life Sciences research uses artificial intelligence to generate smart data and insights to assist in the discovery, clinical development and regulatory compliance of pharmaceutical medicine. On a mission to create self-service products that help enhance decision-making, their platform compiles hundreds of terabytes worth of scientific information spread across clinical trial databases, biological databases, major patent offices, forums and regulatory bodies.